MicroRNA-222 expression and its prognostic potential in non-small cell lung cancer

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Mao, Kai Ping ^a   Zhang, Wei Na ^a   Liang, Xiao Min ^a   Ma, Yu Rong ^a  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 222; MICRORNA; MIRN222 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; IN VITRO STUDY; LUNG TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IN VITRO TECHNIQUES; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84900018694     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/908326     Document Type: Article

References (21)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 2013 63 11 30 10.3322/caac.21166
2. Dutt A., Ramos A. H., Hammerman P. S., Mermel C., Cho J., Sharifnia T., Chande A., Tanaka K. E., Stransky N., Greulich H., Gray N. S., Meyerson M., Inhibitor-sensitive fgfr1 amplification in human non-small cell lung cancer. PLoS ONE 2011 6 6 2-s2.0-79958112619 10.1371/journal.pone.0020351 e20351
3. Coello M. C., Luketich J. D., Litle V. R., Godfrey T. E., Prognostic significance of micrometastasis in non-small-cell lung cancer. Clinical Lung Cancer 2004 5 4 214 225 2-s2.0-1542360634
4. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5
5. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers. Nature 2005 435 7043 834 838 2-s2.0-20444460289 10.1038/nature03702
6. Baraniskin A., Kuhnhenn J., Schlegel U., Chan A., Deckert M., Gold R., Maghnouj A., Zöllner H., Reinacher-Schick A., Schmiegel W., Hahn S. A., Schroers R., Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 2011 117 11 3140 3146 2-s2.0-79953103395 10.1182/blood-2010-09-308684
7. Schetter A. J., Leung S. Y., Sohn J. J., Zanetti K. A., Bowman E. D., Yanaihara N., Yuen S. T., Chan T. L., Kwong D. L. W., Au G. K. H., Liu C.-G., Calin G. A., Croce C. M., Harris C. C., MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. The Journal of the American Medical Association 2008 299 4 425 436 2-s2.0-38749089854 10.1001/jama.299.4.425
8. le Sage C., Nagel R., Egan D. A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafrè S. A., Farace M. G., Agami R., Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. The EMBO Journal 2007 26 15 3699 3708 2-s2.0-34547791273 10.1038/sj.emboj.7601790
9. Hwang M. S., Yu N., Stinson S. Y., miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PloS ONE 2013 8 e66502
10. Lee C., He H., Jiang Y., Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. Medical Oncology 2013 30, article 700 10.1007/s12032-013-0700-y
11. Puerta-Gil P., Garca-Baquero R., Jia A. Y., Ocaa S., Alvarez-Mgica M., Alvarez-Ossorio J. L., Cordon-Cardo C., Cava F., Snchez-Carbayo M., miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. The American Journal of Pathology 2012 180 5 1808 1815 2-s2.0-84860251052 10.1016/j.ajpath.2012.01.034
12. Xu K., Liang X., Shen K., miR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17. Experimental Cell Research 2012 318 2168 2177 10.1016/j.yexcr.2012.04.014
13. Quintavalle C., Garofalo M., Zanca C., Romano G., Iaboni M., del Basso de Caro M., Martinez-Montero J. C., Incoronato M., Nuovo G., Croce C. M., Condorelli G., miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTP Oncogene 2012 31 7 858 868 2-s2.0-84857109002 10.1038/onc.2011.280
14. Zhang Y., Ma T., Yang S., Xia M., Xu J., An H., Yang Y., Li S., High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells. Molecular and Cellular Biochemistry 2011 357 1-2 363 371 2-s2.0-84857421359
15. Gerdes J., Schwab U., Lemke H., Stein H., Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. International Journal of Cancer 1983 31 1 13 20 2-s2.0-0020694123
16. Acunzo M., Visone R., Romano G., Veronese A., Lovat F., Palmieri D., Bottoni A., Garofalo M., Gasparini P., Condorelli G., Chiariello M., Croce C. M., miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 2012 31 5 634 642 2-s2.0-84856533765 10.1038/onc.2011.260
17. Garofalo M., Quintavalle C., di Leva G., Zanca C., Romano G., Taccioli C., Liu C. G., Croce C. M., Condorelli G., MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 2008 27 27 3845 3855 2-s2.0-42749093490 10.1038/onc.2008.6
18. Chun-zhi Z., Lei H., An-Ling Z., Yan-chao F., Xiao Y., Guang-xiu W., Zhi-fan J., Pei-yu P., Qing-yu Z., Chun-sheng K., MicroRNA-221 and MicroRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010 10, article 367 2-s2.0-77955429106 10.1186/1471-2407-10- 367
19. Kedde M., van Kouwenhove M., Zwart W., Oude Vrielink J. A. F., Elkon R., Agami R., A Pumilio-induced RNA structure switch in p27-3°2 UTR controls miR-221 and miR-222 accessibility. Nature Cell Biology 2010 12 10 1014 1020 2-s2.0-77957564277 10.1038/ncb2105
20. Medina R., Zaidi S. K., Liu C.-G., Stein J. L., VanWijnen A. J., Croce C. M., Stein G. S., MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Research 2008 68 8 2773 2780 2-s2.0-42349093068 10.1158/0008-5472.CAN-07-6754
21. Wang Y., Dai W., Chu X., Yang B., Zhao M., Sun Y., Metformin inhibits lung cancer cells proliferation through repressing MicroRNA-222. Biotechnology Letters 2013 35 2013 2019 10.1007/s10529-013-1309-0.